Special Event Series

Clinical Grand Rounds

Our monthly program brings together recognized experts in the mental health and addiction fields to share insights and best practices from their research and clinical experience.

The series includes both virtual and in-person events, and runs every third Thursday of the month from 12-1:30pm.

Pregnancy & Substance Use: Individual Risks

OCTOBER 21, 2021 · 12:00pm – 1:30pm · ONLINE

This event discuss the use of substances during pregnancy, time of exposure and impact on fetus. Specifically, methadone/buprenorphine exposure impact on fetus and long-term effects.
November 18, 2021
Anxiety Disorders and Addiction
12:00pm – 1:30pm
Anxiety disorders and substance use disorders commonly co-occur. This presentation reviews the diagnostic and treatment challenges within the overlap of anxiety disorders (including GAD, panic disorder, PTSD) and addiction.
Katherine Salvador, PA
Root Center for Advanced Recovery
December 16, 2021
Mood Disorders and Addiction
12:00pm – 1:30pm
Mood disorders, including depression and bipolar disorders, are the most common psychiatric comorbidities among patients with substance use disorders. Treating patients’ co-occurring mood disorders may reduce their substance use and enhance their overall outcomes.
Cherie Bochenko, APRN
Root Center for Advanced Recovery
January 20, 2022

Transcranial Magnetic Stimulation and Treating Substance Use Disorders: What We Know and Where We Should Go

12:00pm – 1:30pm
Decades of preclinical and clinical research have taught us that addiction is, indeed, a disorder of dysregulated circuits. Until recently, however, there were no circuit-based treatments for substance use disorders (SUDs).
Vaughn R. Steele, Ph.D.
Assistant Professor of Psychiatry, Division of Addiction Science, Yale Department of Psychiatry, Steele Lab
February 17, 2022
CBT for Addictions
12:00pm – 1:30pm
CBT is a form of therapy used to help clients to identify situations and become aware of thoughts, emotions, and responses through examining inaccurate thinking and negative core beliefs. CBT reshapes these thinking errors through evidence based behavioral experiments and exposure therapy resulting in the client learning to choose different responses to manage their thoughts and emotions.
Kristy Notarangelo, LCSW, MBA
Diplomate of National Academy of Cognitive and Behavioral Therapy
March 17, 2022
Low Dose Buprenorphine Induction Strategies
12:00pm – 1:30pm

Dr. Weimer will outline the reasons for the need for low dose non-traditional buprenorphine induction strategies. She will discuss the clinical scenarios where this technique can be used and different protocols to use.

Melissa Weimer, DO, MCR, FASAM
Assistant Professor of Medicine and Public Health | Yale School of Medicine and Public Health Medical Director, Yale Addiction Medicine Consult Service | Yale New Haven Hospital Associate Program Director, Yale Addiction Medicine Fellowship Program | Yale Program in Addiction Medicine
April 21, 2022
DBT for Treatment of Addiction Disorders
12:00pm – 1:30pm
The basic tenets of Dialectical Behavior Therapy will be reviewed, along with how the skills of Mindfulness, Emotion Regulation, Distress Tolerance, and Interpersonal Skills, can support addiction-based treatment and recovery.
Steven Zuckerman, LPC
President/CEO of Root Center for Advanced Recovery
May 19, 2022
Medical Marijuana: Perspective of a Pharmacist in the Field
12:00pm – 1:30pm
Eric Halpern, PharmD is a pharmacist and assistant manager of Fine Fettle Dispensary in Newington, CT. Eric will be discussing the medical marijuana program in CT, adult use marijuana legislation, mental health considerations with cannabis, and his experience as a pharmacist in the program.
Eric Halpern, PharmD
Assistant Manager – Fine Fettle Dispensary
June 16, 2022
Special Considerations in Adolescent Substance Abuse and Dependence
12:00pm – 1:30pm
Substance abuse is a complex, multi-factorial disorder that requires a team approach to improve the odds of recovery. This is especially true in the adolescent population. Clinicians who treat this population must be aware of the developmental stage in which these patients are, the specific tasks and milestones that must be achieved, as well as the familial, social, and educational factors that contribute to the disease and to recovery.
alejandra wortman
Alejandra Wortman, MD

Child, Adolescent and Adult Psychiatry
Diplomate of the American Board of Psychiatry and Neurology
Assistant Professor, New York Presbyterian Hospital
Department of Psychiatry, Cornell University Medical College

July 15, 2021
The Silence of the Tests: What are we Missing?
12:00pm – 1:30pm
Dr. Jack Kain has worked with multiple toxicology laboratories to develop methodology, content and education on the ever-increasing role of clinical toxicology in pain management, behavioral health and more specifically substance use disorder. In this event, he will cover various topics in drug testing and highlight unique laboratory perspectives on drug misuse.
Jack Kain, PharmD
Director, Medical Science Liaison, Drug Monitoring & Toxicology, San Diego, CA
August 19, 2021

Stress Relief and Mental Self-Care for Those in the Healthcare Field

12:00pm – 1:30pm
Medical research estimates that as much as 90% of illness and disease is stress related and lack of mental wellness is one major cause. Stress and mental wellness has an impact on many other areas of our life such as work performance, mental illness, relationships and weight management.

The training will define trauma, PTSD diagnosis in addiction treatment, identifying stressful events and how troublesome they are to an individual, followed by evidenced based practice treatment approaches.

Participants will:

  1. Describe what is meant by trauma
  2. PTSD in Addiction Treatment
  3. PTSD Diagnosis: Trauma and PTSD
  4. Life Events Checklist
  5. PTSD Checklist (PCL)
  6. Treatment Approaches
Christina Boiano, DC

Private Practice Doctor of Chiropractic

September 16, 2021
Contingency Management Interventions
12:00pm – 1:30pm
Contingency management (CM) is an effective behavioral intervention that provides tangible reinforcement when target behaviors are completed and objectively verified. A large body of literature supports CM’s use for the treatment of persons with substance use disorders (SUDs).
Carla J. Rash, PhD
Associate Professor, Calhoun Cardiology Center, School of Medicine | UConn Health
October 21, 2021
Pregnancy & Substance Use: Individual Risks
12:00pm – 1:30pm
This event discuss the use of substances during pregnancy, time of exposure and impact on fetus. Specifically, methadone/buprenorphine exposure impact on fetus and long-term effects.

Hank Nusbaum, MD, PhD, MBA, FACOG, FASAM

Diplomate of American Board of Obstetrics and Gynecology and American Board of Addiction Medicine, Associate Medical Director, Root Center for Advanced Recovery